Rina-S led to a 50% response rate, including two complete responses, in heavily pretreated advanced endometrial cancer, ...

The study, published earlier this year in the Proceedings of the National Academy of Sciences, examined how abnormal cells ...

A 58-year-old British woman mistook her symptoms of uterine cancer to be those of menopause, and timely intervention from the doctors saved her life. When Dawn Willis from Canterbury suffered from ...

A study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that combining the immunotherapy drug ...

For decades, gynecologic cancer treatment has used aggressive surgical intervention and chemotherapy. These methods often ...

Adding Zyprexa to ondansetron cut nausea and vomiting safely in abdominal/pelvic radiation with low-emetogenic capecitabine.

The trial evaluated the combination of GSK’s Jemperli and Zejula as a first-line therapy for stage III and IV epithelial OC.

This week’s loving giving local donation goes to an organization that helps women and men in the fight against cancer. It all started with Paula’s story and now it’s ...

Jay Harris, who has anchored for SportsCenter for over 10 years has shared he has been diagnosed with prostate cancer and ...

Investing.com -- Genmab (NASDAQ: GMAB) has unveiled new data for its cancer drug Rina-S, which is being tested for use in endometrial cancer. This follows promising early results from trials in ...

An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

Teddi Mellencamp confirmed she’s in a new relationship amid her journey with cancer. Despite the public attention they’ve ...